nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—multiple sclerosis	0.724	1	CpDpCtD
Methylergometrine—CYP3A4—Fingolimod—multiple sclerosis	0.0216	0.246	CbGbCtD
Methylergometrine—HTR1F—trigeminal nerve—multiple sclerosis	0.0208	0.257	CbGeAlD
Methylergometrine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0156	0.193	CbGeAlD
Methylergometrine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0139	0.158	CbGbCtD
Methylergometrine—CYP3A4—Triamcinolone—multiple sclerosis	0.0106	0.12	CbGbCtD
Methylergometrine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0102	0.116	CbGbCtD
Methylergometrine—CYP3A4—Betamethasone—multiple sclerosis	0.00906	0.103	CbGbCtD
Methylergometrine—CYP3A4—Prednisolone—multiple sclerosis	0.00894	0.102	CbGbCtD
Methylergometrine—CYP3A4—Prednisone—multiple sclerosis	0.00844	0.0959	CbGbCtD
Methylergometrine—CYP3A4—Dexamethasone—multiple sclerosis	0.00527	0.0599	CbGbCtD
Methylergometrine—HTR2A—trigeminal nerve—multiple sclerosis	0.0041	0.0506	CbGeAlD
Methylergometrine—DRD1—nerve—multiple sclerosis	0.00384	0.0474	CbGeAlD
Methylergometrine—HTR2A—pons—multiple sclerosis	0.00288	0.0356	CbGeAlD
Methylergometrine—HTR1E—brainstem—multiple sclerosis	0.00282	0.0349	CbGeAlD
Methylergometrine—Atrioventricular block—Fingolimod—multiple sclerosis	0.00229	0.0411	CcSEcCtD
Methylergometrine—HTR2A—pineal body—multiple sclerosis	0.00206	0.0254	CbGeAlD
Methylergometrine—HTR2A—peripheral nervous system—multiple sclerosis	0.00192	0.0237	CbGeAlD
Methylergometrine—HTR1F—nervous system—multiple sclerosis	0.00171	0.0211	CbGeAlD
Methylergometrine—DRD1—brainstem—multiple sclerosis	0.00165	0.0204	CbGeAlD
Methylergometrine—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.00164	0.0295	CcSEcCtD
Methylergometrine—HTR1F—central nervous system—multiple sclerosis	0.00164	0.0203	CbGeAlD
Methylergometrine—HTR2A—nerve—multiple sclerosis	0.0015	0.0185	CbGeAlD
Methylergometrine—HTR1E—nervous system—multiple sclerosis	0.00148	0.0183	CbGeAlD
Methylergometrine—HTR1E—central nervous system—multiple sclerosis	0.00142	0.0176	CbGeAlD
Methylergometrine—HTR1F—brain—multiple sclerosis	0.00131	0.0161	CbGeAlD
Methylergometrine—HTR2C—brainstem—multiple sclerosis	0.00128	0.0158	CbGeAlD
Methylergometrine—Bradycardia—Fingolimod—multiple sclerosis	0.00114	0.0204	CcSEcCtD
Methylergometrine—HTR1E—brain—multiple sclerosis	0.00113	0.014	CbGeAlD
Methylergometrine—DRD1—midbrain—multiple sclerosis	0.00105	0.013	CbGeAlD
Methylergometrine—Cardiac disorder—Fingolimod—multiple sclerosis	0.00103	0.0186	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Cladribine—multiple sclerosis	0.000932	0.0167	CcSEcCtD
Methylergometrine—HTR2C—medulla oblongata—multiple sclerosis	0.000893	0.011	CbGeAlD
Methylergometrine—DRD1—nervous system—multiple sclerosis	0.000863	0.0107	CbGeAlD
Methylergometrine—Palpitations—Fingolimod—multiple sclerosis	0.000858	0.0154	CcSEcCtD
Methylergometrine—Hypertension—Fingolimod—multiple sclerosis	0.000838	0.015	CcSEcCtD
Methylergometrine—DRD1—central nervous system—multiple sclerosis	0.000831	0.0103	CbGeAlD
Methylergometrine—HTR2C—midbrain—multiple sclerosis	0.000816	0.0101	CbGeAlD
Methylergometrine—HTR2C—spinal cord—multiple sclerosis	0.000796	0.00983	CbGeAlD
Methylergometrine—Nervous system disorder—Fingolimod—multiple sclerosis	0.000777	0.0139	CcSEcCtD
Methylergometrine—Sweating increased—Cladribine—multiple sclerosis	0.000769	0.0138	CcSEcCtD
Methylergometrine—Hypotension—Fingolimod—multiple sclerosis	0.00074	0.0133	CcSEcCtD
Methylergometrine—Paraesthesia—Fingolimod—multiple sclerosis	0.000711	0.0128	CcSEcCtD
Methylergometrine—Dyspnoea—Fingolimod—multiple sclerosis	0.000706	0.0127	CcSEcCtD
Methylergometrine—HTR2C—nervous system—multiple sclerosis	0.000671	0.00829	CbGeAlD
Methylergometrine—DRD1—brain—multiple sclerosis	0.00066	0.00815	CbGeAlD
Methylergometrine—HTR2C—central nervous system—multiple sclerosis	0.000646	0.00798	CbGeAlD
Methylergometrine—HTR2A—brainstem—multiple sclerosis	0.000642	0.00793	CbGeAlD
Methylergometrine—HTR2B—nervous system—multiple sclerosis	0.00063	0.00778	CbGeAlD
Methylergometrine—HTR2A—retina—multiple sclerosis	0.00062	0.00765	CbGeAlD
Methylergometrine—HTR2B—central nervous system—multiple sclerosis	0.000607	0.00749	CbGeAlD
Methylergometrine—Cardiac disorder—Cladribine—multiple sclerosis	0.000587	0.0105	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisolone—multiple sclerosis	0.000569	0.0102	CcSEcCtD
Methylergometrine—Diarrhoea—Fingolimod—multiple sclerosis	0.000542	0.00973	CcSEcCtD
Methylergometrine—Dizziness—Fingolimod—multiple sclerosis	0.000524	0.0094	CcSEcCtD
Methylergometrine—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.000523	0.0094	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.000522	0.00937	CcSEcCtD
Methylergometrine—HTR2C—brain—multiple sclerosis	0.000513	0.00633	CbGeAlD
Methylergometrine—Sweating increased—Mitoxantrone—multiple sclerosis	0.000506	0.00908	CcSEcCtD
Methylergometrine—Headache—Fingolimod—multiple sclerosis	0.000496	0.00891	CcSEcCtD
Methylergometrine—HTR2B—brain—multiple sclerosis	0.000482	0.00595	CbGeAlD
Methylergometrine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.000475	0.00852	CcSEcCtD
Methylergometrine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.000475	0.00852	CcSEcCtD
Methylergometrine—Chest pain—Cladribine—multiple sclerosis	0.000468	0.00841	CcSEcCtD
Methylergometrine—HTR2A—medulla oblongata—multiple sclerosis	0.000448	0.00553	CbGeAlD
Methylergometrine—Haematuria—Mitoxantrone—multiple sclerosis	0.000441	0.00792	CcSEcCtD
Methylergometrine—Nervous system disorder—Cladribine—multiple sclerosis	0.00044	0.0079	CcSEcCtD
Methylergometrine—Tachycardia—Cladribine—multiple sclerosis	0.000438	0.00787	CcSEcCtD
Methylergometrine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000434	0.00779	CcSEcCtD
Methylergometrine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000423	0.00759	CcSEcCtD
Methylergometrine—Hypotension—Cladribine—multiple sclerosis	0.00042	0.00753	CcSEcCtD
Methylergometrine—Sweating increased—Prednisolone—multiple sclerosis	0.000415	0.00745	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—multiple sclerosis	0.000414	0.00742	CcSEcCtD
Methylergometrine—HTR2A—midbrain—multiple sclerosis	0.000409	0.00506	CbGeAlD
Methylergometrine—Paraesthesia—Cladribine—multiple sclerosis	0.000403	0.00724	CcSEcCtD
Methylergometrine—Dyspnoea—Cladribine—multiple sclerosis	0.0004	0.00719	CcSEcCtD
Methylergometrine—HTR2A—spinal cord—multiple sclerosis	0.000399	0.00493	CbGeAlD
Methylergometrine—Sweating increased—Triamcinolone—multiple sclerosis	0.000381	0.00685	CcSEcCtD
Methylergometrine—Sweating increased—Methylprednisolone—multiple sclerosis	0.000381	0.00683	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000367	0.00659	CcSEcCtD
Methylergometrine—Abdominal pain—Cladribine—multiple sclerosis	0.000355	0.00637	CcSEcCtD
Methylergometrine—Bradycardia—Prednisolone—multiple sclerosis	0.000347	0.00623	CcSEcCtD
Methylergometrine—Sweating increased—Dexamethasone—multiple sclerosis	0.000346	0.00621	CcSEcCtD
Methylergometrine—Sweating increased—Betamethasone—multiple sclerosis	0.000346	0.00621	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000346	0.0062	CcSEcCtD
Methylergometrine—Hypotension—Azathioprine—multiple sclerosis	0.000341	0.00612	CcSEcCtD
Methylergometrine—HTR2A—nervous system—multiple sclerosis	0.000336	0.00416	CbGeAlD
Methylergometrine—HTR2A—central nervous system—multiple sclerosis	0.000324	0.004	CbGeAlD
Methylergometrine—Bradycardia—Triamcinolone—multiple sclerosis	0.000319	0.00573	CcSEcCtD
Methylergometrine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000318	0.00572	CcSEcCtD
Methylergometrine—HTR2A—cerebellum—multiple sclerosis	0.000317	0.00391	CbGeAlD
Methylergometrine—Convulsion—Mitoxantrone—multiple sclerosis	0.000313	0.00562	CcSEcCtD
Methylergometrine—Hypertension—Mitoxantrone—multiple sclerosis	0.000312	0.0056	CcSEcCtD
Methylergometrine—CYP3A4—nervous system—multiple sclerosis	0.000312	0.00385	CbGeAlD
Methylergometrine—Hallucination—Methylprednisolone—multiple sclerosis	0.000311	0.00559	CcSEcCtD
Methylergometrine—Chest pain—Mitoxantrone—multiple sclerosis	0.000308	0.00553	CcSEcCtD
Methylergometrine—Diarrhoea—Cladribine—multiple sclerosis	0.000307	0.00552	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000305	0.00548	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—multiple sclerosis	0.000301	0.00541	CcSEcCtD
Methylergometrine—CYP3A4—central nervous system—multiple sclerosis	0.0003	0.0037	CbGeAlD
Methylergometrine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000299	0.00536	CcSEcCtD
Methylergometrine—Dizziness—Cladribine—multiple sclerosis	0.000297	0.00533	CcSEcCtD
Methylergometrine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000295	0.0053	CcSEcCtD
Methylergometrine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00029	0.00521	CcSEcCtD
Methylergometrine—Bradycardia—Dexamethasone—multiple sclerosis	0.00029	0.0052	CcSEcCtD
Methylergometrine—Bradycardia—Betamethasone—multiple sclerosis	0.00029	0.0052	CcSEcCtD
Methylergometrine—Abdominal pain—Azathioprine—multiple sclerosis	0.000289	0.00518	CcSEcCtD
Methylergometrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000288	0.00517	CcSEcCtD
Methylergometrine—Vomiting—Cladribine—multiple sclerosis	0.000286	0.00513	CcSEcCtD
Methylergometrine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000285	0.00512	CcSEcCtD
Methylergometrine—Rash—Cladribine—multiple sclerosis	0.000283	0.00508	CcSEcCtD
Methylergometrine—Hallucination—Dexamethasone—multiple sclerosis	0.000283	0.00508	CcSEcCtD
Methylergometrine—Hallucination—Betamethasone—multiple sclerosis	0.000283	0.00508	CcSEcCtD
Methylergometrine—Dermatitis—Cladribine—multiple sclerosis	0.000283	0.00508	CcSEcCtD
Methylergometrine—Headache—Cladribine—multiple sclerosis	0.000281	0.00505	CcSEcCtD
Methylergometrine—Hypotension—Mitoxantrone—multiple sclerosis	0.000276	0.00495	CcSEcCtD
Methylergometrine—Nausea—Cladribine—multiple sclerosis	0.000267	0.00479	CcSEcCtD
Methylergometrine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000265	0.00476	CcSEcCtD
Methylergometrine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000263	0.00472	CcSEcCtD
Methylergometrine—HTR2A—brain—multiple sclerosis	0.000257	0.00318	CbGeAlD
Methylergometrine—Convulsion—Prednisolone—multiple sclerosis	0.000257	0.00461	CcSEcCtD
Methylergometrine—Hypertension—Prednisolone—multiple sclerosis	0.000256	0.0046	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—multiple sclerosis	0.000252	0.00453	CcSEcCtD
Methylergometrine—Diarrhoea—Azathioprine—multiple sclerosis	0.00025	0.00448	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—multiple sclerosis	0.000246	0.00442	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000242	0.00435	CcSEcCtD
Methylergometrine—Dizziness—Azathioprine—multiple sclerosis	0.000241	0.00433	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000241	0.00433	CcSEcCtD
Methylergometrine—Convulsion—Triamcinolone—multiple sclerosis	0.000236	0.00424	CcSEcCtD
Methylergometrine—Tachycardia—Prednisolone—multiple sclerosis	0.000236	0.00424	CcSEcCtD
Methylergometrine—Convulsion—Methylprednisolone—multiple sclerosis	0.000236	0.00423	CcSEcCtD
Methylergometrine—Hypertension—Triamcinolone—multiple sclerosis	0.000236	0.00423	CcSEcCtD
Methylergometrine—Hypertension—Methylprednisolone—multiple sclerosis	0.000235	0.00422	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000234	0.0042	CcSEcCtD
Methylergometrine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000233	0.00419	CcSEcCtD
Methylergometrine—Vomiting—Azathioprine—multiple sclerosis	0.000232	0.00417	CcSEcCtD
Methylergometrine—Rash—Azathioprine—multiple sclerosis	0.00023	0.00413	CcSEcCtD
Methylergometrine—Dermatitis—Azathioprine—multiple sclerosis	0.00023	0.00413	CcSEcCtD
Methylergometrine—Headache—Azathioprine—multiple sclerosis	0.000229	0.00411	CcSEcCtD
Methylergometrine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000223	0.004	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000222	0.00399	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—multiple sclerosis	0.00022	0.00395	CcSEcCtD
Methylergometrine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000218	0.00391	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisolone—multiple sclerosis	0.000217	0.0039	CcSEcCtD
Methylergometrine—Tachycardia—Triamcinolone—multiple sclerosis	0.000217	0.0039	CcSEcCtD
Methylergometrine—Nausea—Azathioprine—multiple sclerosis	0.000217	0.00389	CcSEcCtD
Methylergometrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000217	0.00389	CcSEcCtD
Methylergometrine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000215	0.00386	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000215	0.00386	CcSEcCtD
Methylergometrine—Convulsion—Dexamethasone—multiple sclerosis	0.000215	0.00385	CcSEcCtD
Methylergometrine—Convulsion—Betamethasone—multiple sclerosis	0.000215	0.00385	CcSEcCtD
Methylergometrine—Hypertension—Betamethasone—multiple sclerosis	0.000214	0.00384	CcSEcCtD
Methylergometrine—Hypertension—Dexamethasone—multiple sclerosis	0.000214	0.00384	CcSEcCtD
Methylergometrine—Hypotension—Methylprednisolone—multiple sclerosis	0.000208	0.00373	CcSEcCtD
Methylergometrine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000202	0.00363	CcSEcCtD
Methylergometrine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000202	0.00363	CcSEcCtD
Methylergometrine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000202	0.00363	CcSEcCtD
Methylergometrine—Paraesthesia—Triamcinolone—multiple sclerosis	0.0002	0.00359	CcSEcCtD
Methylergometrine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.0002	0.00358	CcSEcCtD
Methylergometrine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000199	0.00356	CcSEcCtD
Methylergometrine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000198	0.00356	CcSEcCtD
Methylergometrine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000198	0.00356	CcSEcCtD
Methylergometrine—Tachycardia—Dexamethasone—multiple sclerosis	0.000197	0.00354	CcSEcCtD
Methylergometrine—Tachycardia—Betamethasone—multiple sclerosis	0.000197	0.00354	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000195	0.00351	CcSEcCtD
Methylergometrine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000195	0.00351	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—multiple sclerosis	0.000193	0.00346	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000192	0.00345	CcSEcCtD
Methylergometrine—Hypotension—Betamethasone—multiple sclerosis	0.000189	0.00339	CcSEcCtD
Methylergometrine—Hypotension—Dexamethasone—multiple sclerosis	0.000189	0.00339	CcSEcCtD
Methylergometrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000188	0.00337	CcSEcCtD
Methylergometrine—Convulsion—Prednisone—multiple sclerosis	0.000187	0.00335	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—multiple sclerosis	0.000186	0.00334	CcSEcCtD
Methylergometrine—Rash—Mitoxantrone—multiple sclerosis	0.000186	0.00334	CcSEcCtD
Methylergometrine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000186	0.00334	CcSEcCtD
Methylergometrine—Headache—Mitoxantrone—multiple sclerosis	0.000185	0.00332	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000182	0.00326	CcSEcCtD
Methylergometrine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000181	0.00326	CcSEcCtD
Methylergometrine—Paraesthesia—Betamethasone—multiple sclerosis	0.000181	0.00326	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000176	0.00316	CcSEcCtD
Methylergometrine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000176	0.00315	CcSEcCtD
Methylergometrine—Nausea—Mitoxantrone—multiple sclerosis	0.000175	0.00315	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—multiple sclerosis	0.000173	0.0031	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—multiple sclerosis	0.000172	0.00308	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—multiple sclerosis	0.00017	0.00305	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000165	0.00297	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000165	0.00297	CcSEcCtD
Methylergometrine—Dizziness—Prednisolone—multiple sclerosis	0.00016	0.00287	CcSEcCtD
Methylergometrine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00016	0.00287	CcSEcCtD
Methylergometrine—Abdominal pain—Betamethasone—multiple sclerosis	0.00016	0.00287	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—multiple sclerosis	0.000158	0.00284	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—multiple sclerosis	0.000156	0.0028	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—multiple sclerosis	0.000153	0.00275	CcSEcCtD
Methylergometrine—Rash—Prednisolone—multiple sclerosis	0.000153	0.00274	CcSEcCtD
Methylergometrine—Dermatitis—Prednisolone—multiple sclerosis	0.000153	0.00274	CcSEcCtD
Methylergometrine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000152	0.00273	CcSEcCtD
Methylergometrine—Headache—Prednisolone—multiple sclerosis	0.000152	0.00272	CcSEcCtD
Methylergometrine—Dizziness—Triamcinolone—multiple sclerosis	0.000147	0.00264	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000147	0.00264	CcSEcCtD
Methylergometrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000147	0.00264	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000144	0.00259	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000144	0.00258	CcSEcCtD
Methylergometrine—Nausea—Prednisolone—multiple sclerosis	0.000144	0.00258	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000142	0.00255	CcSEcCtD
Methylergometrine—Vomiting—Triamcinolone—multiple sclerosis	0.000142	0.00254	CcSEcCtD
Methylergometrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000141	0.00254	CcSEcCtD
Methylergometrine—Rash—Triamcinolone—multiple sclerosis	0.00014	0.00252	CcSEcCtD
Methylergometrine—Dermatitis—Triamcinolone—multiple sclerosis	0.00014	0.00252	CcSEcCtD
Methylergometrine—Rash—Methylprednisolone—multiple sclerosis	0.00014	0.00251	CcSEcCtD
Methylergometrine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00014	0.00251	CcSEcCtD
Methylergometrine—Headache—Triamcinolone—multiple sclerosis	0.00014	0.0025	CcSEcCtD
Methylergometrine—Headache—Methylprednisolone—multiple sclerosis	0.000139	0.0025	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—multiple sclerosis	0.000139	0.0025	CcSEcCtD
Methylergometrine—Diarrhoea—Betamethasone—multiple sclerosis	0.000138	0.00248	CcSEcCtD
Methylergometrine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000138	0.00248	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—multiple sclerosis	0.000137	0.00247	CcSEcCtD
Methylergometrine—Dizziness—Dexamethasone—multiple sclerosis	0.000134	0.0024	CcSEcCtD
Methylergometrine—Dizziness—Betamethasone—multiple sclerosis	0.000134	0.0024	CcSEcCtD
Methylergometrine—Nausea—Triamcinolone—multiple sclerosis	0.000132	0.00237	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—multiple sclerosis	0.000132	0.00237	CcSEcCtD
Methylergometrine—Nausea—Methylprednisolone—multiple sclerosis	0.000132	0.00237	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—multiple sclerosis	0.000131	0.00235	CcSEcCtD
Methylergometrine—Vomiting—Dexamethasone—multiple sclerosis	0.000128	0.00231	CcSEcCtD
Methylergometrine—Vomiting—Betamethasone—multiple sclerosis	0.000128	0.00231	CcSEcCtD
Methylergometrine—Rash—Betamethasone—multiple sclerosis	0.000127	0.00229	CcSEcCtD
Methylergometrine—Rash—Dexamethasone—multiple sclerosis	0.000127	0.00229	CcSEcCtD
Methylergometrine—Dermatitis—Dexamethasone—multiple sclerosis	0.000127	0.00228	CcSEcCtD
Methylergometrine—Dermatitis—Betamethasone—multiple sclerosis	0.000127	0.00228	CcSEcCtD
Methylergometrine—Headache—Dexamethasone—multiple sclerosis	0.000127	0.00227	CcSEcCtD
Methylergometrine—Headache—Betamethasone—multiple sclerosis	0.000127	0.00227	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—multiple sclerosis	0.00012	0.00216	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00012	0.00216	CcSEcCtD
Methylergometrine—Nausea—Betamethasone—multiple sclerosis	0.00012	0.00215	CcSEcCtD
Methylergometrine—Nausea—Dexamethasone—multiple sclerosis	0.00012	0.00215	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—multiple sclerosis	0.000116	0.00209	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—multiple sclerosis	0.000116	0.00209	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—multiple sclerosis	0.000112	0.00201	CcSEcCtD
Methylergometrine—Rash—Prednisone—multiple sclerosis	0.000111	0.00199	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—multiple sclerosis	0.000111	0.00199	CcSEcCtD
Methylergometrine—Headache—Prednisone—multiple sclerosis	0.00011	0.00198	CcSEcCtD
Methylergometrine—Nausea—Prednisone—multiple sclerosis	0.000105	0.00188	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—multiple sclerosis	0.000101	0.00181	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—multiple sclerosis	9.72e-05	0.00175	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—multiple sclerosis	9.35e-05	0.00168	CcSEcCtD
Methylergometrine—Rash—Methotrexate—multiple sclerosis	9.27e-05	0.00166	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—multiple sclerosis	9.26e-05	0.00166	CcSEcCtD
Methylergometrine—Headache—Methotrexate—multiple sclerosis	9.21e-05	0.00165	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—multiple sclerosis	8.74e-05	0.00157	CcSEcCtD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL10—multiple sclerosis	2.99e-05	0.000586	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCR3—multiple sclerosis	2.98e-05	0.000585	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	2.95e-05	0.00058	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CNR1—multiple sclerosis	2.95e-05	0.000579	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GPR65—multiple sclerosis	2.91e-05	0.000571	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—POMC—multiple sclerosis	2.9e-05	0.00057	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR2—multiple sclerosis	2.9e-05	0.000569	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.85e-05	0.00056	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	2.85e-05	0.00056	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—POMC—multiple sclerosis	2.85e-05	0.000559	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CCL2—multiple sclerosis	2.84e-05	0.000558	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCL5—multiple sclerosis	2.83e-05	0.000556	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL10—multiple sclerosis	2.83e-05	0.000556	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL10—multiple sclerosis	2.82e-05	0.000553	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CCL2—multiple sclerosis	2.78e-05	0.000547	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	2.78e-05	0.000547	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	2.77e-05	0.000544	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—TYK2—multiple sclerosis	2.73e-05	0.000537	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.72e-05	0.000534	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—IL6—multiple sclerosis	2.71e-05	0.000531	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	2.68e-05	0.000526	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CNR1—multiple sclerosis	2.68e-05	0.000525	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCL5—multiple sclerosis	2.67e-05	0.000524	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	2.66e-05	0.000523	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL13—multiple sclerosis	2.66e-05	0.000522	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR1—multiple sclerosis	2.66e-05	0.000522	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL10—multiple sclerosis	2.65e-05	0.000521	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CD86—multiple sclerosis	2.62e-05	0.000515	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	2.59e-05	0.000508	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCL5—multiple sclerosis	2.58e-05	0.000507	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—TYK2—multiple sclerosis	2.58e-05	0.000506	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	2.57e-05	0.000505	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	2.56e-05	0.000502	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	2.55e-05	0.000501	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	2.52e-05	0.000496	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	2.52e-05	0.000494	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.51e-05	0.000494	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—IL2—multiple sclerosis	2.51e-05	0.000492	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	2.48e-05	0.000487	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CD86—multiple sclerosis	2.47e-05	0.000486	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	2.47e-05	0.000485	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.46e-05	0.000483	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCL5—multiple sclerosis	2.44e-05	0.000478	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCL5—multiple sclerosis	2.42e-05	0.000476	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	2.42e-05	0.000475	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL10—multiple sclerosis	2.41e-05	0.000473	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CCR5—multiple sclerosis	2.41e-05	0.000472	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SPP1—multiple sclerosis	2.39e-05	0.00047	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.37e-05	0.000465	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—IL2—multiple sclerosis	2.36e-05	0.000464	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	2.35e-05	0.000461	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCR5—multiple sclerosis	2.33e-05	0.000457	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	2.32e-05	0.000456	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	2.32e-05	0.000455	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	2.31e-05	0.000453	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	2.31e-05	0.000453	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.3e-05	0.000452	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL2RA—multiple sclerosis	2.29e-05	0.00045	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCL5—multiple sclerosis	2.28e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	2.28e-05	0.000448	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL2—multiple sclerosis	2.28e-05	0.000447	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	2.26e-05	0.000444	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SPP1—multiple sclerosis	2.26e-05	0.000443	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PGR—multiple sclerosis	2.23e-05	0.000437	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL3—multiple sclerosis	2.21e-05	0.000435	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCR5—multiple sclerosis	2.19e-05	0.000431	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.19e-05	0.000431	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.19e-05	0.00043	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCR5—multiple sclerosis	2.18e-05	0.000429	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	2.18e-05	0.000429	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL2RA—multiple sclerosis	2.16e-05	0.000425	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CD28—multiple sclerosis	2.16e-05	0.000425	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL2RA—multiple sclerosis	2.15e-05	0.000423	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL2—multiple sclerosis	2.15e-05	0.000421	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTGER4—multiple sclerosis	2.13e-05	0.000418	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	2.12e-05	0.000417	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—APOE—multiple sclerosis	2.12e-05	0.000416	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PGR—multiple sclerosis	2.1e-05	0.000412	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	2.09e-05	0.000411	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL5—multiple sclerosis	2.07e-05	0.000407	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCR3—multiple sclerosis	2.06e-05	0.000404	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	2.06e-05	0.000404	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CD28—multiple sclerosis	2.04e-05	0.0004	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.03e-05	0.000399	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	2.03e-05	0.000398	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR2—multiple sclerosis	2e-05	0.000393	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—APOE—multiple sclerosis	2e-05	0.000392	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	1.99e-05	0.000391	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	1.98e-05	0.000389	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	1.96e-05	0.000385	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CD80—multiple sclerosis	1.91e-05	0.000376	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.9e-05	0.000374	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	1.89e-05	0.000372	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—POMC—multiple sclerosis	1.88e-05	0.000369	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	1.87e-05	0.000367	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CNR1—multiple sclerosis	1.85e-05	0.000363	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	1.84e-05	0.000362	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	1.82e-05	0.000358	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—POMC—multiple sclerosis	1.82e-05	0.000357	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	1.81e-05	0.000355	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CD80—multiple sclerosis	1.81e-05	0.000354	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	1.8e-05	0.000354	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	1.8e-05	0.000353	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.79e-05	0.000351	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCL2—multiple sclerosis	1.78e-05	0.000349	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	1.77e-05	0.000348	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	1.76e-05	0.000346	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.76e-05	0.000346	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	1.76e-05	0.000346	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	1.74e-05	0.000343	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—MAPK1—multiple sclerosis	1.74e-05	0.000342	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—POMC—multiple sclerosis	1.72e-05	0.000337	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	1.71e-05	0.000336	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—POMC—multiple sclerosis	1.71e-05	0.000335	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCL2—multiple sclerosis	1.68e-05	0.000329	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCL2—multiple sclerosis	1.67e-05	0.000328	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL10—multiple sclerosis	1.66e-05	0.000327	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	1.65e-05	0.000323	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—MAPK1—multiple sclerosis	1.64e-05	0.000322	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	1.62e-05	0.000319	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TYK2—multiple sclerosis	1.62e-05	0.000317	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	1.61e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	1.61e-05	0.000316	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.6e-05	0.000314	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	1.58e-05	0.000311	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	1.58e-05	0.00031	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	1.56e-05	0.000306	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.54e-05	0.000303	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.54e-05	0.000303	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CD86—multiple sclerosis	1.54e-05	0.000303	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	1.53e-05	0.0003	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TYK2—multiple sclerosis	1.52e-05	0.000299	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	1.52e-05	0.000298	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TYK2—multiple sclerosis	1.52e-05	0.000298	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	1.52e-05	0.000297	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	1.49e-05	0.000292	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	1.47e-05	0.000289	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.46e-05	0.000287	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CD86—multiple sclerosis	1.46e-05	0.000286	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL5—multiple sclerosis	1.43e-05	0.000281	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.43e-05	0.000281	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.42e-05	0.000279	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.41e-05	0.000277	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	1.41e-05	0.000276	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	1.4e-05	0.000274	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—IL2—multiple sclerosis	1.39e-05	0.000273	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	1.37e-05	0.00027	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	1.37e-05	0.000269	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	1.35e-05	0.000265	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL2—multiple sclerosis	1.34e-05	0.000264	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	1.34e-05	0.000263	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—multiple sclerosis	1.34e-05	0.000263	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SPP1—multiple sclerosis	1.33e-05	0.00026	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.3e-05	0.000255	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR5—multiple sclerosis	1.29e-05	0.000253	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—multiple sclerosis	1.27e-05	0.00025	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2RA—multiple sclerosis	1.27e-05	0.00025	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	1.27e-05	0.000249	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL2—multiple sclerosis	1.27e-05	0.000249	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL2—multiple sclerosis	1.26e-05	0.000248	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—multiple sclerosis	1.26e-05	0.000248	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.24e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.24e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.24e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.24e-05	0.000243	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.23e-05	0.000241	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—multiple sclerosis	1.2e-05	0.000236	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.19e-05	0.000233	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOE—multiple sclerosis	1.17e-05	0.00023	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.00023	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.13e-05	0.000223	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	1.13e-05	0.000222	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.13e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.13e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.1e-05	0.000217	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.09e-05	0.000214	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.08e-05	0.000212	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.08e-05	0.000212	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.07e-05	0.00021	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—multiple sclerosis	1.07e-05	0.000209	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.06e-05	0.000209	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CD80—multiple sclerosis	1.06e-05	0.000208	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MYC—multiple sclerosis	1.05e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	1.05e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.05e-05	0.000205	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.03e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	1.03e-05	0.000202	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.02e-05	0.000201	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—multiple sclerosis	1.01e-05	0.000198	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1e-05	0.000197	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MYC—multiple sclerosis	9.91e-06	0.000195	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—multiple sclerosis	9.89e-06	0.000194	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL2—multiple sclerosis	9.87e-06	0.000194	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	9.85e-06	0.000193	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK1—multiple sclerosis	9.7e-06	0.00019	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	9.66e-06	0.00019	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	9.59e-06	0.000188	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	9.5e-06	0.000187	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	9.45e-06	0.000185	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	9.38e-06	0.000184	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	9.08e-06	0.000178	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	8.96e-06	0.000176	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	8.72e-06	0.000171	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	8.63e-06	0.000169	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	8.44e-06	0.000166	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	8.26e-06	0.000162	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	7.91e-06	0.000155	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—multiple sclerosis	7.9e-06	0.000155	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	7.89e-06	0.000155	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	7.87e-06	0.000154	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	7.67e-06	0.00015	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	7.49e-06	0.000147	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	7.48e-06	0.000147	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL2—multiple sclerosis	7.46e-06	0.000146	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—multiple sclerosis	7.45e-06	0.000146	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	7.42e-06	0.000146	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	7.33e-06	0.000144	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	7.17e-06	0.000141	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	7.06e-06	0.000139	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.72e-06	0.000132	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.66e-06	0.000131	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	6.65e-06	0.000131	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	6.38e-06	0.000125	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	6.35e-06	0.000125	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	6.27e-06	0.000123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	6.18e-06	0.000121	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	6.17e-06	0.000121	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	6.05e-06	0.000119	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	6.04e-06	0.000119	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MYC—multiple sclerosis	5.83e-06	0.000114	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	5.82e-06	0.000114	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	5.7e-06	0.000112	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5.54e-06	0.000109	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	5.51e-06	0.000108	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	5.37e-06	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	5.24e-06	0.000103	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.99e-06	9.79e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.98e-06	9.77e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.88e-06	9.58e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.66e-06	9.15e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	4.65e-06	9.12e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—multiple sclerosis	4.38e-06	8.6e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	4.33e-06	8.5e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	4.32e-06	8.48e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	4.24e-06	8.32e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.04e-06	7.94e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.75e-06	7.36e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.47e-06	6.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	3.26e-06	6.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.17e-06	6.22e-05	CbGpPWpGaD
